NutriStack
Flecainide and Potassium, a caution.
Flecainide has a narrow cardiac safety margin and can cause serious proarrhythmia in susceptible patients. Low potassium is a recognized risk factor for torsades de pointes and can worsen arrhythmia vulnerability when antiarrhythmic drugs are involved. Potassium supplementation is only appropriate for documented or likely deficiency and should be monitored.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Flecainide and Potassium
- Pair type
- Caution
- Evidence (highest tier)
- Emerging
- Source citations
- 3 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Emerging evidence
Caution
What is happening. Flecainide has a narrow cardiac safety margin and can cause serious proarrhythmia in susceptible patients. Low potassium is a recognized risk factor for torsades de pointes and can worsen arrhythmia vulnerability when antiarrhythmic drugs are involved. Potassium supplementation is only appropriate for documented or likely deficiency and should be monitored.
Mechanism. Flecainide primarily blocks fast sodium channels, widening QRS and slowing conduction; rare cases also involve repolarization abnormalities and torsades. Hypokalemia reduces repolarization reserve and promotes early afterdepolarizations, increasing proarrhythmic risk when flecainide exposure or susceptibility is high.
Recommendation. Keep potassium in the normal range while taking flecainide, especially if you use diuretics or have vomiting, diarrhea, or poor intake. Do not start high-dose potassium unless your clinician is checking potassium, kidney function, and ECG status. Seek urgent care for fainting, severe dizziness, wide-complex palpitations, or chest pain.
Sources (3)
- Nasser M, Idris S, Marinelli K, Machado C. Flecainide-induced Torsades de Pointes: Case Report and Review of Literature. Rev Cardiovasc Med. 2015;16(3):214-220. PMID 26451768
- Morganroth J, Horowitz LN. Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. Am J Cardiol. 1984;53(5):89B-94B. PMID 6695821
- Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016;149(3):139-152. PMID 27212965
Stack Score
How this pair moves the number.
Effect on the composite score
If both Flecainide and Potassium are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.